Luciferins

Details Luciferins Luciferins

2011-03-22

2011-03-22

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C435S008000, C435S189000, C514S287000, C514S293000, C514S366000, C546S064000, C546S065000, C546S083000, C548S151000

Reexamination Certificate

active

07910087

ABSTRACT:
Novel luciferins, methods of making luciferins, and uses of the same are disclosed.

REFERENCES:
patent: 5149807 (1992-09-01), Hammond et al.
patent: 5932474 (1999-08-01), Tsien et al.
patent: 6008378 (1999-12-01), Tsien et al.
patent: 6054271 (2000-04-01), Tsien et al.
patent: 6451569 (2002-09-01), Tsien et al.
patent: 6495355 (2002-12-01), Contag et al.
patent: 6686458 (2004-02-01), Tsien et al.
patent: 6737245 (2004-05-01), Francis et al.
patent: 6825355 (2004-11-01), Das et al.
patent: 7524876 (2009-04-01), Takakura et al.
patent: 2003/0083373 (2003-05-01), Tsien et al.
patent: 2003/0087328 (2003-05-01), Pollok et al.
patent: 2003/0157519 (2003-08-01), Zhang et al.
patent: 2003/0166905 (2003-09-01), Wood et al.
patent: 2003/0203404 (2003-10-01), Joly
patent: 2003/0224421 (2003-12-01), Herrmann et al.
patent: 2004/0214227 (2004-10-01), Joly
patent: 2005/0026171 (2005-02-01), Hawkins et al.
patent: 2005/0131217 (2005-06-01), Tsien et al.
patent: 2005/0136449 (2005-06-01), Hanson et al.
patent: 2005/0176065 (2005-08-01), Hanson
patent: 2005/0239135 (2005-10-01), Bogoev et al.
patent: 2005/0272114 (2005-12-01), Darzins et al.
patent: 2006/0073529 (2006-04-01), Contag et al.
patent: 2006/0099679 (2006-05-01), Tsien et al.
patent: 2007/0015790 (2007-01-01), Cali et al.
patent: 2008/0299592 (2008-12-01), Miller
patent: 768176 (2000-09-01), None
patent: 779263 (2001-04-01), None
patent: 1088233 (2001-04-01), None
patent: 2001224398 (2001-08-01), None
patent: WO99/21013 (1999-04-01), None
patent: WO00/49171 (2000-08-01), None
patent: WO01/18195 (2001-03-01), None
patent: WO03/033650 (2003-04-01), None
patent: WO2004/034054 (2004-04-01), None
patent: WO2004/059294 (2004-07-01), None
patent: WO2005/033286 (2005-04-01), None
patent: WO2005/038029 (2005-04-01), None
patent: WO2005/040197 (2005-05-01), None
patent: WO2005/054427 (2005-06-01), None
patent: WO2006/093529 (2006-09-01), None
Adams et al., “New biarsenical ligands and tetracysteine motifs for protein labelingin vitroandin vivo: synthesis and biological,” J. Am. Chem. Soc. 124:6063-76 (2002).
Arai et al., “Detection of protein-protein interaction by bioluminescence resonance energy transfer from firefly luciferase to red fluorescent protein, ” J. Biosci. Bioeng. 94 :362-364 (2002).
Branchini et al., “Red- and green-emitting firefly luciferase mutants for bioluminescent reporter applications”, Anal. Biochem. 345(1):140 (2005).
Contag et al., “Advances in vivo bioluminescence imaging of gene expression, ” Annu. Rev. Biomed. Eng. 4:235-620 (2002).
Griffin, B. A. et al., “Specific covalent labeling of recombinant protein molecules inside live cells”, Science 281: 269-272 (1998).
Gurskaya et al., “GFP-like chromoproteins as a source of far-red fluorescent proteins,” FEBS Lett. 507(1) :16-20 (2001).
Martin et al., “Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescene and affmity,” Nat. Biotechnol. 23 :1308-14 (2005).
Nakanishi et al., “Imaging of conformational changes of proteins with a new environment-sensitive fluorescent probe designed for site-specific labeling of recombinant proteins in live cells,” Anal. Chem. 73:2920-28 (2001).
Rice et al., “In vivoimaging of light-emitting probes, ” Journal of Biomedical Optics 6:432-440 (2001).
Shaner et al., “Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein, ” Nat. Biotechnol. 22 :1567-1572 (2004).
So et al., “Self-illuminating quantum dot conjugates forin vivoimaging,” Nat. Biotechnol. 24(3) :339-43 (2006).
Tirat et al., “Evaluation of two novel tag-based labeling technologies for site-specific modification of proteins,” Int. J. Biol. Macromol. 39 :66-76 (2006).
Viviani et al., “Cloning, sequence analysis, and expression of active Phrixothrix railroad-worms luciferases: relationship between bioluminescence spectra and primary structures,” Biochemistry 38:8271-79 (1999).
Viviani et al., “The influence of A1a243 (G1y247), Arg215 and Thr226 (Asn230) on the bioluminescence spectra and pH-sensitivity of railroad worm, check beetle and firefly luciferases,” Photochem. Photobiol. 76 :538-44 (2002).
Wang et al., “Renilla luciferase- Aequorea GFP (Ruc-GFP) fusion protein, a novel dual reporter for real-time imaging of gene expression cell cultures and in live animals,” Mol. Genet. Genomics 268 :160-168 (2002).
Weissleder et al., “Shedding light onto live molecular targets,” Nat. Med. 9(1):123-8 (2003).
White et al., “Amino analogs of firefly luciferin and biological activity thereof,” JACS 88:2015 (1966).
Xu, Y. et al., “A bioluminescence resonance energy transfer (BRET) system: Application to interacting circadian clock proteins,” Proc. Natl. Acad. Sci. USA 96: 151-156 (1999).
Xu et al., “Bioluminescence resonance energy transfer: monitoring protein-protein interactions in living cells,” Methods Enzymol. 360 :289-301 (2003).
Yamakawa et al., “Rapid homogeneous immunoassay of peptides based on bioluminescence resonance energy transfer from firefly luciferase,” J. Biosci. Bioeng. 93 :537-542 (2002).

Affiliated with

Also associated with

Rating

Luciferins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Luciferins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luciferins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2704851